Winner of the Best Vaccine R&D Pipeline: @sanofipasteur #wvcusa
The Best Pharmaceutical Vaccine Pipeline was open to international Pharmaceutical and Biotechnology organizations.
The criteria used to judge this category will be as follows:
- Size and range of the overall vaccine pipeline
- Mix across development phases
- Spread across innovation and lower risk candidate development
- Commitment to R&D productivity model implementation
- Current and future market potential and value for the pipeline
Winner: sanofi Pasteur
Judges specific comments on the winner included:
• 1. 13 investigative vaccines in clinical development, across new and second generation vaccines, improved vaccines and combination vaccines make it a truly comprehensive portfolio.
• 2. 5 vaccines in phase III with 2 candidates receiving FDA fast-track status to meet an unmet need provides real measurable progress
Well done sanofi Pasteur
***********************************************
Highly Regarded’ recommendation: Novartis Vaccines and Diagnostics who’s pipeline progress in 2011 continues to offer a strong, diverse range of candidates across many development phases
